A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Evaluate the Effect of AMG 785 on Parameters of Bone Quality of the Forearm Using pQCT in Postmenopausal Women With Low Bone Mineral Density.
Phase of Trial: Phase I
Latest Information Update: 03 Feb 2011
At a glance
- Drugs Romosozumab (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 03 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 27 Mar 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.